O	0	6	Intake
O	7	9	of
B-intervention	10	17	vitamin
I-intervention	18	19	D
I-intervention	20	23	and
I-intervention	24	31	calcium
I-intervention	31	32	,
I-intervention	33	36	sun
I-intervention	37	45	exposure
O	45	46	,
O	47	50	and
O	51	55	risk
O	56	58	of
O	59	65	breast
O	66	72	cancer
O	73	81	subtypes
O	82	87	among
O	88	93	black
O	94	99	women
O	99	100	.

O	101	104	The
O	105	115	randomized
O	116	123	placebo
O	123	124	-
O	124	134	controlled
O	135	142	Vitamin
O	143	144	D
O	145	148	and
O	149	154	Omega
O	154	155	-
O	155	156	3
O	157	162	Trial
O	163	172	suggested
O	173	174	a
O	175	183	possible
O	184	191	benefit
O	192	194	of
O	195	202	vitamin
O	203	204	D
O	205	207	on
O	208	214	cancer
O	215	224	incidence
O	225	230	among
B-ethinicity	231	236	black
O	237	248	individuals
O	248	249	.

O	250	257	However
O	257	258	,
O	259	263	data
O	264	267	are
O	268	275	limited
O	276	285	regarding
O	286	289	the
O	290	296	impact
O	297	299	of
O	300	307	vitamin
O	308	309	D
O	310	312	on
O	313	319	breast
O	320	326	cancer
O	327	335	subtypes
O	336	341	among
B-ethinicity	342	349	African
I-ethinicity	349	350	-
I-ethinicity	350	358	American
I-ethinicity	358	359	/
I-ethinicity	359	364	black
O	365	370	women
O	370	371	,
O	372	375	who
O	376	380	tend
O	381	383	to
O	384	391	develop
O	392	396	more
O	397	407	aggressive
O	408	413	forms
O	414	416	of
O	417	423	breast
O	424	430	cancer
O	430	431	.

O	432	434	We
O	435	446	hypothesize
O	447	451	that
O	452	456	more
O	457	464	vitamin
O	465	466	D
O	467	475	exposure
O	476	477	(
O	477	484	through
O	485	489	diet
O	489	490	,
O	491	502	supplements
O	502	503	,
O	504	507	and
O	508	516	sunlight
O	516	517	)
O	518	521	and
O	522	528	higher
O	529	535	intake
O	536	538	of
O	539	546	calcium
O	547	550	are
O	551	561	associated
O	562	566	with
O	567	576	decreased
O	577	581	risk
O	582	584	of
O	585	593	estrogen
O	594	602	receptor
O	603	604	(
O	604	606	ER
O	606	607	)
O	607	608	+
O	609	612	and
O	613	615	ER
O	615	616	-
O	617	623	breast
O	624	630	cancer
O	630	631	,
O	632	635	and
O	636	638	of
O	639	645	triple
O	645	646	-
O	646	654	negative
O	655	661	breast
O	662	668	cancer
O	669	670	(
O	670	674	TNBC
O	674	675	)
O	676	681	among
O	682	687	black
O	688	693	women
O	693	694	.

O	695	699	This
O	700	705	study
O	706	709	was
O	710	719	conducted
O	720	725	among
B-intervention-participants	726	730	1724
O	731	736	black
O	737	742	cases
O	743	746	and
B-control-participants	747	751	1233
B-control	752	760	controls
O	761	763	in
O	764	767	the
O	768	773	Women
O	773	774	'
O	774	775	s
O	776	782	Circle
O	783	785	of
O	786	792	Health
O	793	798	Study
O	799	800	(
O	800	804	WCHS
O	804	805	)
O	806	809	and
O	810	815	WCHS2
O	815	816	.

O	817	827	Polytomous
O	828	836	logistic
O	837	848	regressions
O	849	853	were
O	854	858	used
O	859	861	to
O	862	870	estimate
O	871	874	ORs
O	875	878	and
O	879	881	95
O	881	882	%
O	883	886	CIs
O	887	889	of
O	890	892	ER
O	892	893	+
O	894	897	and
O	898	900	ER
O	900	901	-
O	902	908	breast
O	909	915	cancer
O	915	916	;
O	917	925	logistic
O	926	937	regressions
O	938	942	were
O	943	947	used
O	948	951	for
O	952	956	TNBC
O	956	957	.

O	958	961	The
O	962	965	ORs
O	966	970	from
O	971	975	each
O	976	981	study
O	982	986	were
O	987	993	pooled
O	994	999	using
O	1000	1002	an
O	1003	1010	inverse
O	1010	1011	-
O	1011	1019	variance
O	1019	1020	-
O	1020	1028	weighted
O	1029	1035	random
O	1035	1036	-
O	1036	1043	effects
O	1044	1049	model
O	1049	1050	.

B-outcome	1051	1058	Dietary
I-outcome	1059	1066	vitamin
I-outcome	1067	1068	D
I-outcome	1069	1072	and
I-outcome	1073	1080	calcium
I-outcome	1081	1087	intake
O	1088	1092	were
O	1093	1096	not
O	1097	1107	associated
O	1108	1112	with
O	1113	1117	risk
O	1118	1120	of
O	1121	1127	breast
O	1128	1134	cancer
O	1135	1143	subtypes
O	1144	1146	in
O	1147	1150	the
O	1151	1157	pooled
O	1158	1166	analysis
O	1166	1167	.

O	1168	1171	For
O	1172	1184	supplemental
O	1185	1192	vitamin
O	1193	1194	D
O	1194	1195	,
O	1196	1198	we
O	1199	1207	observed
O	1208	1216	possible
O	1217	1224	inverse
O	1225	1237	associations
O	1238	1245	between
O	1246	1252	intake
O	1253	1255	of
O	1256	1257	â‰¤
O	1257	1260	800
O	1261	1263	IU
O	1263	1264	/
O	1264	1265	d
O	1266	1267	(
O	1267	1275	compared
O	1276	1280	with
O	1281	1287	nonuse
O	1287	1288	)
O	1289	1292	and
B-outcome	1293	1297	risk
I-outcome	1298	1300	of
I-outcome	1301	1308	several
I-outcome	1309	1317	subtypes
O	1317	1318	,
O	1319	1323	with
O	1324	1331	effects
O	1332	1336	that
O	1337	1345	appeared
O	1346	1355	strongest
O	1356	1359	for
O	1360	1364	TNBC
O	1365	1366	(
O	1366	1368	OR
O	1368	1369	:
O	1370	1371	0
O	1371	1372	.
O	1372	1374	58
O	1374	1375	;
O	1376	1378	95
O	1378	1379	%
O	1380	1382	CI
O	1382	1383	:
O	1384	1385	0
O	1385	1386	.
O	1386	1388	35
O	1388	1389	,
O	1390	1391	0
O	1391	1392	.
O	1392	1394	94
O	1394	1395	)
O	1395	1396	;
O	1397	1399	no
O	1400	1411	association
O	1412	1415	was
O	1416	1421	found
O	1422	1425	for
O	1426	1427	>
O	1427	1430	800
O	1431	1433	IU
O	1433	1434	/
O	1434	1435	d
O	1435	1436	.

O	1437	1441	More
O	1442	1450	daylight
O	1451	1456	hours
O	1457	1462	spent
O	1463	1471	outdoors
O	1472	1474	in
O	1475	1476	a
O	1477	1481	year
O	1482	1485	was
O	1486	1496	associated
O	1497	1501	with
O	1502	1507	lower
B-outcome	1508	1512	risk
I-outcome	1513	1515	of
I-outcome	1516	1518	ER
I-outcome	1518	1519	+
I-outcome	1519	1520	,
I-outcome	1521	1523	ER
I-outcome	1523	1524	-
I-outcome	1524	1525	,
I-outcome	1526	1529	and
I-outcome	1530	1534	TNBC
O	1535	1536	(
O	1536	1537	e
O	1537	1538	.
O	1538	1539	g
O	1539	1540	.
O	1540	1541	,
O	1542	1549	highest
O	1550	1558	compared
O	1559	1563	with
O	1564	1570	lowest
O	1571	1579	quartile
O	1579	1580	:
O	1581	1585	TNBC
O	1586	1588	OR
O	1588	1589	:
O	1590	1591	0
O	1591	1592	.
O	1592	1594	53
O	1594	1595	;
O	1596	1598	95
O	1598	1599	%
O	1600	1602	CI
O	1602	1603	:
O	1604	1605	0
O	1605	1606	.
O	1606	1608	31
O	1608	1609	,
O	1610	1611	0
O	1611	1612	.
O	1612	1614	91
O	1614	1615	;
O	1616	1617	P
O	1617	1618	-
O	1618	1623	trend
O	1624	1625	=
O	1626	1627	0
O	1627	1628	.
O	1628	1630	02
O	1630	1631	)
O	1631	1632	.

O	1633	1641	Moderate
O	1642	1654	supplemental
O	1655	1662	vitamin
O	1663	1664	D
O	1665	1671	intake
O	1672	1675	was
O	1676	1686	associated
O	1687	1691	with
O	1692	1701	decreased
O	1702	1706	risk
O	1707	1709	of
O	1710	1714	TNBC
O	1714	1715	,
O	1716	1719	and
O	1720	1729	increased
O	1730	1733	sun
O	1734	1742	exposure
O	1743	1746	was
O	1747	1757	associated
O	1758	1762	with
O	1763	1770	reduced
O	1771	1775	risk
O	1776	1778	of
O	1779	1781	ER
O	1781	1782	+
O	1782	1783	,
O	1784	1786	ER
O	1786	1787	-
O	1787	1788	,
O	1789	1792	and
O	1793	1797	TNBC
O	1798	1803	among
O	1804	1809	black
O	1810	1815	women
O	1815	1816	.
